Detalhe da pesquisa
1.
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.
Acta Haematol
; 144(5): 585-590, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735874
2.
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
Cancer
; 125(11): 1855-1866, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811597
3.
FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.
Blood
; 129(14): 1958-1968, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143883
4.
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome.
Hematol Oncol
; 37(1): 96-102, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153704
5.
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Am J Hematol
; 94(7): 757-766, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963592
6.
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
Acta Haematol
; 142(3): 176-184, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112940
7.
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
Cancer
; 124(13): 2704-2713, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682723
8.
Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R.
Am J Hematol
; 93(10): 1245-1253, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051599
9.
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
Biochim Biophys Acta
; 1863(4): 562-71, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26704388
10.
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Am J Hematol
; 92(3): 238-243, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28006851
11.
Targeting acute myeloid leukemia with TP53-independent vosaroxin.
Future Oncol
; 13(2): 125-133, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27615555
12.
A mind map for managing minimal residual disease in acute myeloid leukemia.
Clin Adv Hematol Oncol
; 15(11): 859-867, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29200419
13.
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Cancer
; 122(18): 2857-66, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27244347
14.
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
Am J Hematol
; 91(12): 1221-1226, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27474808
15.
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient.
Am J Hematol
; 95(9): 1117-1120, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356323
16.
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
Br J Haematol
; 167(3): 356-65, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066676
17.
More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
Blood
; 129(18): 2584-2587, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246192
18.
Increased peripheral leukemia blasts leading to false-positive blood culture.
Blood Cells Mol Dis
; 64: 8-9, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285097
19.
Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML.
Am J Hematol
; 92(1): 119-120, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27341684
20.
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations.
Front Oncol
; 10: 1538, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984009